Position in NVAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,158,998
+$689,989 QoQ
Shares Held
229,193
+27.0% QoQ
Ownership
0.139%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 263 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,554,498,511 across 303 Biotechnology names. NVAX ranks #151 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in NVAX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,158,998 | 229,193 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,469,009 | 180,468 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,061,383 | 157,944 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,656,542 | 191,066 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,153,813 | 183,145 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,148,268 | 179,137 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $643,714 | 80,064 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,139,516 | 90,223 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $918,558 | 72,556 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $267,652 | 56,065 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $229,873 | 47,937 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $385,131 | 53,195 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $393,737 | 52,993 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $400,768 | 57,831 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $474,298 | 46,138 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $829,610 | 45,583 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,217,147 | 43,110 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,261,001 | 44,277 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $31,097,265 | 217,357 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $96,589,667 | 465,919 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $82,742,302 | 389,724 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $149,176,066 | 822,768 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $38,584,467 | 346,018 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $20,712,186 | 191,160 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $19,062,478 | 228,704 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||